NVR Trademark

Trademark Overview


On Tuesday, October 1, 2013, a trademark application was filed for NVR with the United States Patent and Trademark Office. The USPTO has given the NVR trademark a serial number of 79139587. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Monday, September 23, 2024. This trademark is owned by NOVARTIS AG. The NVR trademark is filed in the Pharmaceutical Products category with the following description:

[Pharmaceutical products, namely, Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals;] Cardiovascular pharmaceuticals;[ Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; ]Pharmaceutical preparations acting on the central nervous system;[ Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases;] Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system,[ the musculo-skeletal system and the genitourinary system;] pharmaceutical preparations for use in hematology and in tissue and organ transplantation; [Pharmaceutical preparations for the treatment of eye diseases and conditions; ]Pharmaceutical preparations for the treatment of heart rhythm disorders;[ Pharmaceutical preparations for the treatment of immune system related diseases...
nvr

General Information


Serial Number79139587
Word MarkNVR
Filing DateTuesday, October 1, 2013
Status706 - SECTION 71 ACCEPTED
Status DateMonday, September 23, 2024
Registration Number4634793
Registration DateTuesday, November 11, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 26, 2014

Trademark Statements


Goods and Services[Pharmaceutical products, namely, Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals;] Cardiovascular pharmaceuticals;[ Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; ]Pharmaceutical preparations acting on the central nervous system;[ Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases;] Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system,[ the musculo-skeletal system and the genitourinary system;] pharmaceutical preparations for use in hematology and in tissue and organ transplantation; [Pharmaceutical preparations for the treatment of eye diseases and conditions; ]Pharmaceutical preparations for the treatment of heart rhythm disorders;[ Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes;] Pharmaceutical preparations for treating hypertension;[ Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; ]Pharmaceutical products for the prevention and treatment of cancer[; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 13, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel 4002
CH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4002
CH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel 4002
CH

Trademark Events


Event DateEvent Description
Thursday, December 12, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 13, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 17, 2013APPLICATION FILING RECEIPT MAILED
Thursday, December 19, 2013ASSIGNED TO EXAMINER
Thursday, December 19, 2013NON-FINAL ACTION WRITTEN
Friday, December 20, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, December 20, 2013REFUSAL PROCESSED BY MPU
Friday, December 20, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, January 11, 2014REFUSAL PROCESSED BY IB
Friday, April 11, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 11, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 5, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 5, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 5, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 27, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 14, 2014ASSIGNED TO LIE
Saturday, July 19, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 6, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 6, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 6, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, August 22, 2014NOTIFICATION PROCESSED BY IB
Tuesday, August 26, 2014PUBLISHED FOR OPPOSITION
Tuesday, August 26, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 11, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, February 11, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, April 2, 2015FINAL DISPOSITION PROCESSED
Thursday, April 2, 2015FINAL DISPOSITION NOTICE SENT TO IB
Saturday, May 2, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, November 11, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, April 6, 2020TEAS SECTION 71 & 15 RECEIVED
Saturday, May 9, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 1, 2020REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Tuesday, September 1, 2020NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Friday, June 9, 2023INTERNATIONAL REGISTRATION RENEWED
Saturday, November 11, 2023COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Monday, January 15, 2024TEAS SECTION 71 RECEIVED
Monday, September 23, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 23, 2024REGISTERED-SEC.71 ACCEPTED
Monday, September 23, 2024NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Friday, May 23, 2025PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, September 27, 2025INVALIDATION PROCESSED
Saturday, September 27, 2025PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, October 31, 2025PARTIAL INVALIDATION PROCESSED BY THE IB